UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Rapid diagnostic tests for infectious diseases in the emergency department

Clinical microbiology and infection, 2021-02, Vol.27 (2), p.182-191

2021

Volltextzugriff (PDF)

SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates

The Journal of hospital infection, 2023-02, Vol.132, p.140-142

2023

Volltextzugriff (PDF)

Intensive care management of patients with viral encephalitis

Revue neurologique, 2022-01, Vol.178 (1-2), p.48-56

2022

Volltextzugriff (PDF)

Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands

Clinical microbiology and infection, 2020-06, Vol.26 (6), p.785.e1-785.e4

2020

Volltextzugriff (PDF)

Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?

Clinical microbiology and infection, 2014-02, Vol.20 (2), p.136-144

2014

Volltextzugriff (PDF)

Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards

Infectious diseases now (Online), 2022-06, Vol.52 (4), p.208-213

2022

Volltextzugriff (PDF)

Multiplex PCR implementation as point-of-care testing in a French emergency department

The Journal of hospital infection, 2020-06, Vol.105 (2), p.337-338

2020

Volltextzugriff (PDF)

Approche syndromique multiplexe en réanimation

Médecine intensive réanimation, 2019-06, Vol.28 (3), p.217-231

2019

Volltextzugriff (PDF)

Corrigendum to “HIV-2 molecular epidemiology” [Infect. Genet. Evol. 46 (2016) 233–240]

Infection, genetics and evolution, 2018-03, Vol.58, p.294-294

2018

Volltextzugriff (PDF)

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1237-1242

2013

Volltextzugriff (PDF)

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.718-721

2019

Volltextzugriff (PDF)

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)

Médecine et maladies infectieuses, 2020-05, Vol.50 (3), p.243-251

2020

Volltextzugriff (PDF)

Virus respiratoires dans les pneumonies associées aux soins

Médecine intensive réanimation, 2018-05, Vol.27 (3), p.217-227

2018

Volltextzugriff (PDF)

Early assessment of viral respiratory epidemics for the 2023/2024 season based on community laboratory surveillance network in France

Clinica chimica acta, 2024-05, Vol.558, p.119244, Article 119244

2024

Volltextzugriff (PDF)

Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact

Critical care medicine, 2022-07, Vol.50 (7), p.e643

2022

Volltextzugriff (PDF)

Dolutegravir in HIV-2–Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

Clinical infectious diseases, 2015-05, Vol.60 (10), p.1521-1527

2015

Volltextzugriff (PDF)

NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment

Journal of global antimicrobial resistance., 2014-06, Vol.2 (2), p.103-106

2014

Volltextzugriff (PDF)

Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity: J Virol

Journal of virology, 2020, Vol.94 (7)

2020

Volltextzugriff (PDF)

Molecular Determinants of HIV-2 R5-X4 Tropism in the V3 Loop: Development of a New Genotypic Tool

The Journal of infectious diseases, 2012-01, Vol.205 (1), p.111-120

2012

Volltextzugriff (PDF)

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1507-1512

2015

Volltextzugriff (PDF)

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

Journal of antimicrobial chemotherapy, 2020-01, Vol.75 (1), p.183-193

2020

Volltextzugriff (PDF)

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

Journal of antimicrobial chemotherapy, 2019-05, Vol.74 (5), p.1417-1424

2019

Volltextzugriff (PDF)

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

Journal of antimicrobial chemotherapy, 2014-10, Vol.69 (10), p.2819-2825

2014

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(80)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rapid diagnostic tests for infectious diseases in the emergency department

SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates

Intensive care management of patients with viral encephalitis

Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands

Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?

Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards

Multiplex PCR implementation as point-of-care testing in a French emergency department

Approche syndromique multiplexe en réanimation

Corrigendum to “HIV-2 molecular epidemiology” [Infect. Genet. Evol. 46 (2016) 233–240]

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)

Virus respiratoires dans les pneumonies associées aux soins

Early assessment of viral respiratory epidemics for the 2023/2024 season based on community laboratory surveillance network in France

Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact

Dolutegravir in HIV-2–Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment

Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity: J Virol

Molecular Determinants of HIV-2 R5-X4 Tropism in the V3 Loop: Development of a New Genotypic Tool

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

Suchergebnisse filtern